Jamil Atef Chahrour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jamil Atef Chahrour has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Zaher Abdel Baki
College of Engineering and Technology, American University of the Middle East, Egaila
4 shared publications - Akram Hijazi
Research Platform for Environmental Science (EDST-PRASE), Doctoral School, Lebanese University, Beirut 1003, Lebanon
3 shared publications - Dalia El Badan
Department of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria 21511, Egypt
2 shared publications - Ghassan Nasser
Doctoral School of Science and Technology, Research Platform for Environmental Science (PRASE), Lebanese University, P.O. Box 115020, Beirut 1107-2809, Lebanon
2 shared publications - Marc Maresca
Aix Marseille Univ, CNRS, Centrale Med, ISM2, 13013 Marseille, France
2 shared publications Adla Jammoul
Laboratory of Microbiology, Medical Laboratory Department, Faculty of Public Health-I, Lebanese University, Beirut
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by PAGEPress Publications in Italian Journal of Food Safety
Assessment of antibiotic residues and microbiological safety in Lebanese dairy products: Akkawi cheese, yogurt, and labneh, collected across Lebanese dairy industries
Antibiotic residues in dairy products and the resulting antibiotic-resistant bacteria represent a major global public health concern. This study evaluated the microbiological safety of 400 dairy samples collected over two consecutive years (2022 and 2023) from 16 dairy residue industries across four governorates in Lebanon. In addition, antibiotic residues were screened from 126 dairy product samples randomly chosen out of the 400. An optimized multi-class method for the identification and quantification of 30 antibiotics was developed using liquid chromatography-mass spectrometry. Results revealed that 48% of the analyzed samples were contaminated with at least one antibiotic residue, among which 33% showed co-occurrence of multiple antibiotic classes. Meanwhile, microbiological assessment of 400 dairy samples collected over 2 years from the same dairies revealed higher levels of contamination with total coliforms, Escherichia coli, and Staphylococcus aureus in Akkawi cheese samples collected during the first year (44%, 32%, and 15%, respectively) compared to those collected the second year (38.8%, 31%, and 0%). Moderate contamination levels were observed in Labneh (strained yogurt) samples collected during both seasons, with yeast (12%; 11%), molds (1.2%; 11%), total coliforms (6%; 11%), and Escherichia coli (3.7%; 11%). On the other hand, comparable levels of non-conformity were observed in yogurt samples across the two years, with contamination by yeast (7.5%; 6.2%), molds (3.75%; 6.2%), total coliforms (26%; 31.2%), E. coli (20%; 21%), and Staphylococcus aureus (1.25%; 0%). Escherichia coli isolates exhibited resistance to tetracycline while being 100% sensitive to ciprofloxacin and nalidixic acid. As for S. aureus isolates, they presented a high sensitivity to tetracyclines, doxycycline, and ciprofloxacin. These findings highlight the importance of implementing and maintaining good hygienic practices within dairy industries. Antimicrobial residues of oxytetracycline, tetracycline, ciprofloxacin, sulfamethazine, and doxycycline were detected at levels below the maximum residue limits.
- 13 October 2026
- Published by PAGEPress Publications in Italian Journal of Food Safety
Open AccessAssessment of antibiotic residues and microbiological safety in Lebanese dairy products: Akkawi cheese, yogurt, and labneh, collected across Lebanese dairy industries
Antibiotic residues in dairy products and the resulting antibiotic-resistant bacteria represent a major global public health concern. This study evaluated the microbiological safety of 400 dairy samples collected over two consecutive years (2022 and 2023) from 16 dairy residue industries across four governorates in Lebanon. In addition, antibiotic residues were screened from 126 dairy product samples randomly chosen out of the 400. An optimized multi-class method for the identification and quantification of 30 antibiotics was developed using liquid chromatography-mass spectrometry. Results revealed that 48% of the analyzed samples were contaminated with at least one antibiotic residue, among which 33% showed co-occurrence of multiple antibiotic classes. Meanwhile, microbiological assessment of 400 dairy samples collected over 2 years from the same dairies revealed higher levels of contamination with total coliforms, Escherichia coli, and Staphylococcus aureus in Akkawi cheese samples collected during the first year (44%, 32%, and 15%, respectively) compared to those collected the second year (38.8%, 31%, and 0%). Moderate contamination levels were observed in Labneh (strained yogurt) samples collected during both seasons, with yeast (12%; 11%), molds (1.2%; 11%), total coliforms (6%; 11%), and Escherichia coli (3.7%; 11%). On the other hand, comparable levels of non-conformity were observed in yogurt samples across the two years, with contamination by yeast (7.5%; 6.2%), molds (3.75%; 6.2%), total coliforms (26%; 31.2%), E. coli (20%; 21%), and Staphylococcus aureus (1.25%; 0%). Escherichia coli isolates exhibited resistance to tetracycline while being 100% sensitive to ciprofloxacin and nalidixic acid. As for S. aureus isolates, they presented a high sensitivity to tetracyclines, doxycycline, and ciprofloxacin. These findings highlight the importance of implementing and maintaining good hygienic practices within dairy industries. Antimicrobial residues of oxytetracycline, tetracycline, ciprofloxacin, sulfamethazine, and doxycycline were detected at levels below the maximum residue limits.
- Open Access
- 14 May 2026
- Published by Open Exploration Publishing in Exploration of Neuroscience
- Vol. 5, 1006137
Thymoquinone in Alzheimer’s disease: experimental evidence and neuroprotective mechanisms
Thymoquinone (TQ), the main bioactive constituent of Nigella sativa, has gained great attention for its neuroprotective properties, especially for Alzheimer’s disease (AD), which is a progressive neurodegenerative disorder with limited therapeutic options. This review provides several experimental evidence on the effects of TQ in AD models. The evidences indicate that TQ reduces the amyloid-β accumulation, reduces the oxidative stress and neuroinflammation, and improves cognitive and behavioral outcomes. Additionally, TQ should be able to promote the neuronal survival and neurogenesis while reducing biological markers that indicate brain damage or neuron loss. Although these findings clearly highlight and show the promising therapeutic potential of the TQ molecule in the AD, it is important to note that further in-depth studies are still needed to fully understand its underlying molecular mechanisms and to determine its clinical relevance in patients.
- 14 May 2026
- Published by Open Exploration Publishing in Exploration of Neuroscience
- Vol. 5, 1006137
Open AccessThymoquinone in Alzheimer’s disease: experimental evidence and neuroprotective mechanisms
Thymoquinone (TQ), the main bioactive constituent of Nigella sativa, has gained great attention for its neuroprotective properties, especially for Alzheimer’s disease (AD), which is a progressive neurodegenerative disorder with limited therapeutic options. This review provides several experimental evidence on the effects of TQ in AD models. The evidences indicate that TQ reduces the amyloid-β accumulation, reduces the oxidative stress and neuroinflammation, and improves cognitive and behavioral outcomes. Additionally, TQ should be able to promote the neuronal survival and neurogenesis while reducing biological markers that indicate brain damage or neuron loss. Although these findings clearly highlight and show the promising therapeutic potential of the TQ molecule in the AD, it is important to note that further in-depth studies are still needed to fully understand its underlying molecular mechanisms and to determine its clinical relevance in patients.
- Open Access
- 1 December 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (12) , 1674
Herbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action
In recent years, herbal medicines (HMs) have been gaining significant attention as alternative or complementary therapeutic options. This is because synthetic drugs are expensive and have side effects, but also because herbal medicines have a rich content of effective bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of chronic diseases including cardiovascular disorders, infections, metabolic disorders, neurological disorders, inflammatory disorders digestive diseases, oxidative stress-related diseases, and diabetes mellitus. In this review, we highlight the roles and impacts of various medicinal plants originating from diverse families, showing their bioactive characteristics, and the mechanisms through which they exert antidiabetic effects by regulating insulin secretion, oxidative stress, glucose uptake, and inflammatory pathways. In contrast to previous reviews, our study highlights the role of plants that are less explored, and integrates recent findings as well as future directions and biotechnological applications in plant-based management of diabetes.
- 1 December 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (12) , 1674
Open AccessHerbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action
In recent years, herbal medicines (HMs) have been gaining significant attention as alternative or complementary therapeutic options. This is because synthetic drugs are expensive and have side effects, but also because herbal medicines have a rich content of effective bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of chronic diseases including cardiovascular disorders, infections, metabolic disorders, neurological disorders, inflammatory disorders digestive diseases, oxidative stress-related diseases, and diabetes mellitus. In this review, we highlight the roles and impacts of various medicinal plants originating from diverse families, showing their bioactive characteristics, and the mechanisms through which they exert antidiabetic effects by regulating insulin secretion, oxidative stress, glucose uptake, and inflammatory pathways. In contrast to previous reviews, our study highlights the role of plants that are less explored, and integrates recent findings as well as future directions and biotechnological applications in plant-based management of diabetes.
- Open Access
- 22 October 2025
- Published by MDPI AG in Preprints.org
Herbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by an impaired insulin secretion (or action), leading to persistent hyperglycemia. Such a disease, associated with multiple risk factors, can be broadly classified into two major types: Type 1 and type 2 diabetes. In recent years, herbal medicines (HMs) have been gaining significant attention as alternatives or complementary therapeutic options, owing to their rich content of bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of several chronic diseases, including (i) cardiovascular disorders, (ii) infections, and notably (iii) diabetes mellitus. In this present state-of-the art review, we highlight the roles and impacts of various medicinal plants originating from diverse families upon emphasizing their active phytoconstituents, and the mechanisms through which they exert antidiabetic effects. Special emphasis is placed on how these bioactive ingredients can modulate glucose metabolism, enhance insulin sensitivity, and ultimately mitigate complications related to diabetes.
- 22 October 2025
- Published by MDPI AG in Preprints.org
Open AccessHerbal Medicines in the Management of Diabetes Mellitus: Plants, Bioactive Compounds, and Mechanisms of Action
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by an impaired insulin secretion (or action), leading to persistent hyperglycemia. Such a disease, associated with multiple risk factors, can be broadly classified into two major types: Type 1 and type 2 diabetes. In recent years, herbal medicines (HMs) have been gaining significant attention as alternatives or complementary therapeutic options, owing to their rich content of bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of several chronic diseases, including (i) cardiovascular disorders, (ii) infections, and notably (iii) diabetes mellitus. In this present state-of-the art review, we highlight the roles and impacts of various medicinal plants originating from diverse families upon emphasizing their active phytoconstituents, and the mechanisms through which they exert antidiabetic effects. Special emphasis is placed on how these bioactive ingredients can modulate glucose metabolism, enhance insulin sensitivity, and ultimately mitigate complications related to diabetes.